Latest Institute for Science and International Security Stories
Including Phone Call Answered by Member of ISIS; U.S.
- Isis Outperforms 2014 Projections for Pro Forma Net Operating Loss and Year-end Cash CARLSBAD, Calif., Feb. 27, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
CARLSBAD, Calif., Feb. 24, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from a Phase 1 study with ISIS-PKK(Rx).
CARLSBAD, Calif., Feb. 10, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
CHICAGO, Jan. 27, 2015 /PRNewswire/ -- The struggle against ISIS is the latest in what seems like a never-ending war on terror that has cost trillions of dollars and thousands of lives.
WASHINGTON, Dec. 18, 2014 /PRNewswire-USNewswire/ -- A number of leading Senators and national security experts criticized U.S.
ST. PETERSBURG, Fla., Dec.
CARLSBAD, Calif., Dec. 5, 2014 /PRNewswire/ -- Stanley T. Crooke, Ph.D., M.D., founder, CEO and chairman of the board of directors of Isis Pharmaceuticals, Inc.
- Webcast scheduled on Monday, December 8 at 9:00 a.m. Eastern Time CARLSBAD, Calif., Nov. 18, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
- A bereavement by loss of parents or children; the state of being orbate; orbation.